Jul 26, 05:00 AM

Mayne Pharma Sues Sun Pharma; Stock Hits ₹1,711.95, Up 2.80%

Australia’s Mayne Pharma has filed a lawsuit against Indian drugmaker Sun Pharma over patent infringement. Despite the legal issues, Sun Pharma's stock has surged, reaching a 52-week high. On July 25, Sun Pharma’s stock hit ₹1,658 per share. The stock continued to rise, reaching an all-time high of ₹1,711.95 per share on July 26, soaring up to 2.80% on the BSE.

#Australia #Mayne Pharma #Indian #Sun Pharma

Written with ChatGPT (GPT-4o).

Sources

The Morning Context@MorningContext
2 years ago
While Sun Pharma is facing patent infringement allegations from Melbourne-based Mayne Pharmaceuticals, it’s not been an issue for its investors. Sun Pharma’s stock reached a 52-week high recently, reaching ₹1,658 per share on July 25. Read more: https://t.co/LqsJdwFsbg
Business Standard@bsindia
2 years ago
#MarketsWithBS | Sun Pharmaceutical's stock soared up to 2.80%, hitting all time high at 1711.95 per share on the BSE in Friday’s intraday trade. #SUNPHARMA #buzzingstocks #StockMarket https://t.co/VIXr7IWoep
The Morning Context@MorningContext
2 years ago
Amid patent infringement allegations, Sun Pharma has seen a 52-week high surge in stock. The pharma giant’s legal issues do not seem to be a deterrent for investors at the moment. Read more: https://t.co/LqsJdwG00O

Additional media

Image #1 for story mayne-pharma-sues-sun-pharma-stock-hits-1711-95-up-2-80